» Articles » PMID: 27125771

Feasibility of PRIME: A Cognitive Neuroscience-Informed Mobile App Intervention to Enhance Motivated Behavior and Improve Quality of Life in Recent Onset Schizophrenia

Overview
Journal JMIR Res Protoc
Publisher JMIR Publications
Specialty General Medicine
Date 2016 Apr 30
PMID 27125771
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Despite improvements in treating psychosis, schizophrenia remains a chronic and debilitating disorder that affects approximately 1% of the US population and costs society more than depression, dementia, and other medical illnesses across most of the lifespan. Improving functioning early in the course of illness could have significant implications for long-term outcome of individuals with schizophrenia. Yet, current gold-standard treatments do not lead to clinically meaningful improvements in outcome, partly due to the inherent challenges of treating a population with significant cognitive and motivational impairments. The rise of technology presents an opportunity to develop novel treatments that may circumvent the motivational and cognitive challenges observed in schizophrenia.

Objective: The purpose of this study was two-fold: (1) to evaluate the feasibility and acceptability of implementing a Personalized Real-Time Intervention for Motivation Enhancement (PRIME), a mobile app intervention designed to target reward-processing impairments, enhance motivation, and thereby improve quality of life in recent onset schizophrenia, and (2) evaluate the empirical benefits of using an iterative, user-centered design (UCD) process.

Methods: We conducted two design workshops with 15 key stakeholders, followed by a series of in-depth interviews in collaboration with IDEO, a design and innovation firm. The UCD approach ultimately resulted in the first iteration of PRIME, which was evaluated by 10 RO participants. Results from the Stage 1 participants were then used to guide the next iteration that is currently being evaluated in an ongoing RCT. Participants in both phases were encouraged to use the app daily with a minimum frequency of 1/week over a 12-week period.

Results: The UCD process resulted in the following feature set: (1) delivery of text message (short message service, SMS)-based motivational coaching from trained therapists, (2) individualized goal setting in prognostically important psychosocial domains, (3) social networking via direct peer-to-peer messaging, and (4) community "moments feed" to capture and reinforce rewarding experiences and goal achievements. Users preferred an experience that highlighted several of the principles of self-determination theory, including the desire for more control of their future (autonomy and competence) and an approach that helps them improve existing relationships (relatedness). IDEO, also recommended an approach that was casual, friendly, and nonstigmatizing, which is in line with the recovery model of psychosis. After 12-weeks of using PRIME, participants used the app, on average, every other day, were actively engaged with its various features each time they logged in and retention and satisfaction was high (20/20, 100% retention, high satisfaction ratings). The iterative design process lead to a 2- to 3-fold increase in engagement from Stage 1 to Stage 2 in almost each aspect of the platform.

Conclusions: These results indicate that the neuroscience-informed mobile app, PRIME, is a feasible and acceptable intervention for young people with schizophrenia.

Citing Articles

Technology use and interest in digital apps for mental health promotion and lifestyle intervention among young adults with serious mental illness.

Naslund J, Aschbrenner K J Affect Disord Rep. 2025; 6.

PMID: 40027518 PMC: 11870643. DOI: 10.1016/j.jadr.2021.100227.


Putting measurement-based care into action: a multi-method study of the benefits of integrating routine client feedback in coordinated specialty care programs for early psychosis.

Meyer-Kalos P, Owens G, Fisher M, Wininger L, Williams-Wengerd A, Breen K BMC Psychiatry. 2024; 24(1):871.

PMID: 39623335 PMC: 11610165. DOI: 10.1186/s12888-024-06258-1.


Engagement and Acceptability of Acceptance and Commitment Therapy in Daily Life in Early Psychosis: Secondary Findings From a Multicenter Randomized Controlled Trial.

van Aubel E, Vaessen T, Uyttebroek L, Steinhart H, Beijer-Klippel A, Batink T JMIR Form Res. 2024; 8:e57109.

PMID: 39570655 PMC: 11621719. DOI: 10.2196/57109.


Leveraging Personal Technologies in the Treatment of Schizophrenia Spectrum Disorders: Scoping Review.

DArcey J, Torous J, Asuncion T, Tackaberry-Giddens L, Zahid A, Ishak M JMIR Ment Health. 2024; 11:e57150.

PMID: 39348196 PMC: 11474131. DOI: 10.2196/57150.


Acceptability and usability of a WeChat-based intervention for depression in China: A mixed-methods study.

Tan Y, Lattie E, Xiang H, Tang H, Teng Z, Qiu Y Digit Health. 2024; 10:20552076241262301.

PMID: 39229461 PMC: 11369882. DOI: 10.1177/20552076241262301.


References
1.
Saarni S, Viertio S, Perala J, Koskinen S, Lonnqvist J, Suvisaari J . Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry. 2010; 197(5):386-94. DOI: 10.1192/bjp.bp.109.076489. View

2.
Foussias G, Remington G . Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr Bull. 2008; 36(2):359-69. PMC: 2833114. DOI: 10.1093/schbul/sbn094. View

3.
Kring A, Barch D . The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol. 2014; 24(5):725-36. PMC: 4020953. DOI: 10.1016/j.euroneuro.2013.06.007. View

4.
Sarkar S, Hillner K, Velligan D . Conceptualization and treatment of negative symptoms in schizophrenia. World J Psychiatry. 2016; 5(4):352-61. PMC: 4694548. DOI: 10.5498/wjp.v5.i4.352. View

5.
Gard D, Sanchez A, Starr J, Cooper S, Fisher M, Rowlands A . Using self-determination theory to understand motivation deficits in schizophrenia: the 'why' of motivated behavior. Schizophr Res. 2014; 156(2-3):217-22. PMC: 4084414. DOI: 10.1016/j.schres.2014.04.027. View